Israel - hebraico - Ministry of Health

cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - תרכיז להכנת תמיסה לאינפוזיה - phytomenadione 15 mcg/ml; ergocalciferol 0.5 mcg/ml; tocopherol 0.91 mg/ml; retinol palmitate 194.1 mcg/ml - combinations - combinations - vitalipid n adult is indicated in adult and children above 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.

Israel - hebraico - Ministry of Health

cure medical & technical supply - ergocalciferol; phytomenadione; retinol palmitate; tocopherol - תרכיז להכנת תמיסה לאינפוזיה - phytomenadione 20 mcg/ml; ergocalciferol 1 mcg/ml; tocopherol 0.64 mg/ml; retinol palmitate 135.3 mcg/ml - combinations of electrolytes - combinations of electrolytes - vitalipid n infants is indicated in infants and children up to 11 years of age as a supplement in iv nutrition to meet the daily requirement of the fat soluble vitamins a, d2, e,k1.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

Israel - hebraico - Ministry of Health

romat ltd - acetylmethionine 20 mg/ml; arginine 2.4 mg/ml - solution for injection - supplement of vitamins, amino acid and sugars

Israel - hebraico - Ministry of Health

abbott medical laboratories ltd - ascorbic acid 13 mg / 100 ml; biotin 32 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - complete balance nutrition for diets or supplementation for those requiring unordinary feeding.

Israel - hebraico - Ministry of Health

abbott medical laboratories ltd - ascorbic acid 70 mg / 100 ml; betacarotene 3 mg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - liquid nutrition for metaboliacally stressed patients.

Israel - hebraico - Ministry of Health

abbott medical laboratories ltd - ascorbic acid 35.3 mg / 100 ml; biotin 56.3 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - high calorie, complete balanced nutrion, for liquid diets or supplementation.

Israel - hebraico - Ministry of Health

abbott medical laboratories ltd - ascorbic acid 65 mg / 100 ml; biotin 57.6 mcg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - ready to use, high - nitrogen isotonic liquid nutrition.

Israel - hebraico - Ministry of Health

vitamed pharmaceutical industries ltd - dipyrone - סירופ - dipyrone 1.25 g / 5 ml - pyrazolones - relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.

Israel - hebraico - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.